1)Mitchell P, Bandello F, Schmidt-Erfurth U et al:The RESTORE study:ranibizumab monotherapy or combined with laser versus laser monotherapy for diabetic macular edema. Ophthalmology 118:615-625, 2011
2)Ishibashi T, Li X, Koh A et al:The REVEAL Study:Ranibizumab monotherapy or combined with laser versus laser monotherapy in Asian patients with diabetic macular edema. Ophthalmology 122:1402-1415, 2015
3)Brown DM, Nguyen QD, Marcus DM et al:Long-term outcomes of ranibizumab therapy for diabetic macular edema:the 36-month results from two phase Ⅲ trials:RISE and RIDE. Ophthalmology 120:2013-2022, 2013
4)Korobelnik JF, Do DV, Schmidt-Erfurth U et al:Intravitreal aflibercept for diabetic macular edema. Ophthalmology 121:2247-2254, 2014
5)Do DV, Nguyen QD, Boyer D et al:One-year outcomes of the da Vinci Study of VEGF Trap-Eye in eyes with diabetic macular edema. Ophthalmology 119:1658-1665, 2012
6)Diabetic Retinopathy Clinical Research Network; Browning DJ, Glassman AR, Aiello LP et al:Relationship between optical coherence tomography-measured central retinal thickness and visual acuity in diabetic macular edema. Ophthalmology 114:525-536, 2007
7)Otani T, Kishi S, Maruyama Y:Patterns of diabetic macular edema with optical coherence tomography. Am J Ophthalmol 127:688-693, 1999
8)宇山紘史・宮本紀子・山本庄吾・他:糖尿病黄斑浮腫に対するアフリベルセプト硝子体内注射の短期注射成績.眼臨紀9:889-893,2016
9)塚越美奈・塩川律子・後藤洋平・他:糖尿病黄斑浮腫に対するVEGF阻害薬の治療成績.臨眼71:1455-1458,2017
10)Elman MJ, Ayala A, Bressler NM et al:Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment:5-year randomized trial results. Ophthalmology 122:375-381, 2015
11)Spaide R:Ranibizumab according to need:a treatment for age-related macular degeneration. Am J Ophthalmol 143:679-680, 2007
12)Ohnaka M, Nagai Y, Sho K et al:A modified treat-and-extend regimen of aflibercept for treatment-naïve patients with neovascular age-related macular degeneration. Graefes Arch Clin Exp Ophthalmol 255:657-664, 2017
13)Prünte C, Fajnkuchen F, Mahmood S et al:Ranibizumab 0.5 mg treat-and-extend regimen for diabetic macular oedema:the RETAIN study. Br J Ophthalmol 100:787-795, 2016
14)Shimura M, Yasuda K, Yasuda M et al:Visual outcome after intravitreal bevacizumab depends on the optical coherence tomographic patterns of patients with diffuse diabetic macular edema. Retina 33:740-747, 2013
15)村上智昭・鈴間 潔・宇治彰人・他:漿液性網膜剝離を伴う糖尿病黄斑浮腫に対するラニビズマブの投与回数.日眼会誌121:585-592,2017
16)Klein KA, Cleary TS, Reichel E:Effect of intravitreal aflibercept on recalcitrant diabetic macular edema. Int J Retina Vitreous 3:1-7, 2017
17)Fouda SM, Bahgat AM:Intravitreal aflibercept versus intravitreal ranibizumab for the treatment of diabetic macular edema. Clin Ophthalmol 11:567-571, 2017